Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003783 |
---|---|
Receipt number | R000004238 |
Scientific Title | A multicenter randomized phase II/III trial of preoperative versus postoperative chemotherapy with XELOX plus bevacizumab in patients with resectable colorectal liver metastasis. |
Date of disclosure of the study information | 2010/07/01 |
Last modified on | 2019/04/21 12:53:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/06/19 00:42:33 | ||
2 | Update | 2013/12/21 01:19:15 | TEL Homepage URL Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2017/12/24 09:45:08 | Name of primary person or sponsor Institute Institute Organization Organization Organization Category of Funding Organization |
|
4 | Update | 2018/05/27 11:12:16 | Recruitment status Last follow-up date Date of closure to data entry Date analysis concluded |
|
5 | Update | 2018/06/14 17:34:57 | UMIN ID1 |
|
6 | Update | 2019/04/21 12:43:27 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
7 | Update | 2019/04/21 12:47:48 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
8 | Update | 2019/04/21 12:53:55 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |